Evidence map›Paper›PMID 32592075›Full record

ArticleJournal of assisted reproduction and genetics2020

Pregnancy after oocyte donation in a patient with NLRP7 gene mutations and recurrent molar hydatidiform pregnancies.

Claire Cozette, Florence Scheffler, Melyne Lombart, Jerome Massardier, Pierre-Adrien Bolze, Touria Hajri, Francois Golfier, Isabelle Touitou, Cecile Rittore, Jean Gondry and 3 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of assisted reproduction and genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Cancers · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Decoding the Genetics of Recurrent Molar Pregnancy.Journal of human reproductive sciences
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Claire CozetteCentre Hospitalier Amiens Sud, Amiens Cedex 1, France. Cozette.Claire@chu-amiens.fr.
Florence SchefflerCentre Hospitalier Amiens Sud, Amiens Cedex 1, France.
Melyne LombartCentre Hospitalier Amiens Sud, Amiens Cedex 1, France.
Jerome MassardierCentre Hospitalier Lyon Sud, Lyon, France.
Pierre-Adrien BolzeCentre Hospitalier Lyon Sud, Lyon, France.
Touria HajriCentre Hospitalier Lyon Sud, Lyon, France.
Francois GolfierCentre Hospitalier Lyon Sud, Lyon, France.
Isabelle TouitouCHRU, Montpellier, France.
Cecile RittoreCHRU, Montpellier, France.
Jean GondryCentre Hospitalier Amiens Sud, Amiens Cedex 1, France.
Philippe MervielCHRU, Brest, France.
Moncef BenkhalifaCentre Hospitalier Amiens Sud, Amiens Cedex 1, France.
Rosalie CabryCentre Hospitalier Amiens Sud, Amiens Cedex 1, France.
Centre Hospitalier Universitaire Amiens-Picardie · FRHôpital Lyon Sud · FRInstitut national de l'environnement industriel et des risques · FRCentre Hospitalier Régional Universitaire de Brest · FRHCL Technologies (India) · INPérinatalité & Risques Toxiques · FRService de la Santé Publique · CHUniversité de Picardie Jules Verne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molar pregnancies are benign trophoblastic diseases associated with a risk of malignant transformation. If aetiology remains mostly unknown, the risk of recurrent molar pregnancy is around 1.5% after one molar pregnancy and around 25% after 2 molar pregnancies. In the later situation, genetic mutations have been described, increasing hugely this risk. In case of mutations, probability to obtain a normal pregnancy is estimated around 1.8%. We report the case of a Caucasian 30-year-old woman whose previous five spontaneous pregnancies had a negative outcome: a spontaneous miscarriage and then 4 complete hydatidiform moles. Genetic testing revealed that the patient carried two heterozygous mutations in the NLRP7 gene (c.2982-2A > G and Y318CfsX7). According to this, counselling was conducted to advocate for oocyte donation in order to obtain a normal pregnancy. This technique enabled a complication-free, singleton pregnancy that resulted in a healthy term live birth of a 2900 g female. Few months after delivery, the patient presented a new complete hydatidiform mole. Women presented with mutations in the NLRP7, KHDC3L or PADI6 genes are unlikely to obtain normal pregnancies, with a major risk of reproductive failure. In such a context, oocyte donation may be the best option. Only 4 normal pregnancies and deliveries have been published in this situation through this technique to our knowledge.

Indexed as

Abortion, SpontaneousAdaptor Proteins, Signal TransducingAdultFemaleHumansHydatidiform MoleMutationNeoplasm Recurrence, LocalNeoplasmsOocyte DonationPregnancyPregnancy Complications, NeoplasticAdaptor Proteins, Signal TransducingNLRP7 protein, humanNLRP7 gene mutationOocyte donationRecurrent hydatidiform moleTrophoblastic disease

Identifiers

PMID32592075
PMCPMC7492304
OpenAlexW3038100537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.